Moretus Research initiated coverage of Albemarle (ALB) with a Strong Buy rating and a $125 price target, citing deep undervaluation and robust volume growth driven by project ramps and cost discipline. The firm believes Albemarle's volume-led strategy and supply chain optimization will lead to margin outperformance, with free cash flow breakeven expected in FY25. While risks related to lithium pricing and project execution exist, the current valuation presents an attractive risk/reward profile.
Moretus Research has initiated coverage on Albemarle Corporation (ALB) with a "Strong Buy" rating and a $125 price target, citing a significant undervaluation of the company. The positive outlook is predicated on anticipated robust volume growth stemming from new project ramps and disciplined cost management. Albemarle's volume-centric strategy, buttressed by existing contract coverage and supply chain optimization, is expected to drive margin outperformance, even within a scenario of flat lithium prices. Furthermore, disciplined capital allocation and cost efficiencies are projected to enhance cash conversion and liquidity, positioning Albemarle to achieve free cash flow breakeven in fiscal year 2025. While Moretus Research acknowledges inherent risks related to lithium pricing volatility and the execution of projects, the current market valuation is assessed as offering a highly asymmetric risk/reward profile, particularly ahead of an anticipated cyclical or structural reset in the lithium market. Albemarle's role as a key global supplier of specialty lithium compounds for applications like next-generation batteries underpins this fundamental view.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment